by Kall Kwik WGC | Oct 9, 2018 | Free Library
September, 2018 SMM-185 Big pharma, little pharma Why, for smaller firms, imitating large firms may be a less viable approach than imitating other small firms.
by Kall Kwik WGC | Aug 14, 2018 | Free Library
July, 2018 SMM-184 Brand teams: why are some smarter than others? In practice, all brand teams recruit from the same labour pool, adopt industry-standard processes and buy data from the usual sources. It’s unrealistic to expect your people to be...
by Kall Kwik WGC | Aug 2, 2018 | Free Library
August, 2018 SMM-183 Keytruda’s Secret Sauce Why Merck’s position in oncology is about much more than a good product.
by Kall Kwik WGC | Jul 9, 2018 | Free Library
June, 2018 SMM-180 Less is more In most life science companies, the brand plan document is not fit for purpose. Intended to communicate the plan and gain commitment, It is typically a time-consuming tome that is rarely read and often ridiculed....
by Kall Kwik WGC | Jul 9, 2018 | Free Library
June, 2018 SMM-181 Malthus’ orphans Firms focusing on small, high-profit niches risk falling into a 200-year-old trap.
by Kall Kwik WGC | Jul 9, 2018 | Free Library
June, 2018 SMM-182 The Genetically Modified Marketer The turbulent confluence of technological and sociological change means that it is impossible to step into the same market twice. Marketers must also change and adapt to the shifting demands...
